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????????????
Larygoscopy and tracheal intubation increase activi-
ty of the sympathetic nervous system and release of 
catecholamine, resulted in adverse events, such as hy-
pertension, tachycardia, cardiac arrhythmias, and coro-
nary ischemia1〜5）. Many studies have been performed 
to prevent hyperdynamic responses induced by tra-
cheal intubation. The mechanism by which laryngosco-
py and tracheal intubation induce the hemodynamic 
changes are associated with systemic catecholamine 
release. Of various classes of drugs, narcotics or b 1-ad-
renoceptor antagonists have frequently been used to 
prevent such detrimental events. Since remifentanil 
has a shorter duration of action and suppresses auto-
nomic and hemodynamic responses to noxious stimula-
tion, it may be suitable to avoid adverse hemodynamic 
effects induced by tracheal intubation7〜11）. Landiolol, a 
newer, ultra-short-acting b 1-adrenoceptor antagonist, 
has recently been used to prevent hemodynamic re-
sponses induced by intubation12〜17）. However, little is 
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???????
The purpose of this study is to compare remifentanil with landiolol to examine the effects of hemodynam-
ic and plasma catecholamine responses to tracheal intubation. Sixty patients scheduled for elective surgery 
were randomly divided into three groups, to receive either normal saline （group C）, a 1-minute loading in-
fusion of remifentanil 0.5 mg/kg followed by an infusion of remifentanil 0.25/mg/kg/min during the study 
（group R）, or a 1-minute loading infusion of landiolol 0 .125 mg/kg followed by an infusion of landiolol 
0.04 mg/kg/min during the study （group L）. After the 1-minute loading infusion of each drug, anesthesia 
was induced with intravenous injection of propofol 2 mg/kg, and vecuronium 0.1 mg/kg. Five minutes after 
the administration of each drug, tracheal intubation was performed within 30 seconds. Mean arterial pres-
sure remained below the baseline value after tracheal intubation in group R, but not in groups L and C. 
Heart rate significantly increased after tracheal intubation in group C, but not in groups R and L. Plasma 
concentration of adrenaline remained below the baseline value after tracheal intubation in all groups, but it 
was significantly lower in group R, compared with other groups. Plasma concentration of noradrenaline sig-
nificantly increased after tracheal intubation in groups L and C, but not in group R. Bispectral index in 
group R remained lower than that in groups L and C after tracheal intubation. Remifentanil may be prefera-
ble to landiolol to provide cardiovascular stability after tracheal intubation.
???? ????： remifentanil, landiolol, tracheal intubation, adrenaline, noradrenaline
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min during the study （remifentanil group）, or 3） a 
1-minute loading infusion of landiolol 0.125 mg/kg fol-
lowed by an infusion of landiolol 0.04 mg/kg/min using 
an automated infusion pump during the study （landi-
olol group）. One minute after the start of administra-
tion of each drug, anesthesia was induced with intrave-
nous injection of propofol 2 mg/kg. After loss of 
consciousness, vecuronium 0 .1 mg/kg was adminis-
tered intravenously. After mask ventilation with 100％ 
oxygen, the trachea was intubated 5 minutes after the 
start of administration of saline, remifentanil, or landi-
olol. Each intubation was performed by an experienced 
anesthesiologist, who was blinded to the drug, and was 
accomplished within 30 seconds. After tracheal intuba-
tion, the ventilator was adjusted initially to deliver a 
tidal volume of 9 mL/kg and respiratory rate of 10 
breaths/min. End-tidal carbon dioxide tension （PET-
CO2） was maintained at 35-40 mm Hg during the 
study. Anesthesia was maintained with 66％ air in ox-
ygen supplemented with sevoflurane 2％ . All patients 
received a continuous infusion of acetate Ringer’s solu-
tion at a rate of 5 mL/kg/h during the study.
Measurements of mean arterial pressure （MAP）, 
heart rate （HR）, and BIS values were performed be-
fore anesthesia （baseline）, after induction of anesthe-
sia, and one, 5 and 10 minutes after intubation.
Plasma adrenaline and noradrenaline were measured 
by high-performance liquid chromatography before 
anesthesia （baseline）, after induction of anesthesia, and 
immediately, 5 and 10 minutes after intubation.
Data are presented as mean±SD. Intergroup differ-
ences were analyzed by two-way analysis of variance 
for the repeated-measures design. When a significant 
overall effect was detected, Scheffé’s test was used for 
comparison of the mean values for the two variables. 
Comparison between both groups was made by apply-
known about the effect of remifentanil versus landiolol 
on plasma catecholamines release during tracheal intu-
bation.
In the present study, we examined the differential 
effects of remifentanil and landiolol on hemodynamic 
and plasma catecholamines responses during tracheal 
intubation.
?????????????????????
After approval of the ethics committee of Dokkyo 
Medical University School of Medicine and written, in-
formed consent, 60 ASA physical status 1 or 2 patients 
aged 20-62 years, within 15％ of ideal body weight, 
who were scheduled to undergo elective surgery un-
der general anesthesia, were studied. Patients with 
predicted difficulty in tracheal intubation were exclud-
ed from the study. No patients were receiving any 
medication.
A 20-mL syringe containing an equivalent volume 
of either normal saline, landiolol or remifentanil was 
prepared in advance by an anesthesiologist not in-
volved in the data collection. Patients were prospec-
tively randomized via sealed envelope assignment, to 
one of three groups.
No premedication was given. After patient arrival at 
the operation room, the left radial artery was cannulated 
to measure systolic and diastolic blood pressure, and 
plasma adrenaline and noradrenaline levels. Pulse oxi-
metry （Satlite；Datex-Ohmeda, Madison, WI, USA）, 
capnography （Capnomac；Datex-Ohmeda） and the 
bispectral index （BIS；model A1050, version 3.4, As-
pect Medical Systems, USA） were monitored. Sixty 
patients were divided into three groups of 20 patients 
each to receive either 1） normal saline （saline group）, 
2） a 1-minute loading infusion of remifentanil 0.5 mg/
kg followed by an infusion of remifentanil 0.25 mg/kg/
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?????　Demographic data
saline
（n＝20）
remifentanil
（n＝20）
landiolol
（n＝20）
P
Age（yrs） 55±14 58±11 58± 8 n.s.
Height（cm） 158± 9 161± 9 158±10 n.s.
Weight（kg） 59±11 58± 8 58±11 n.s.
Gender（male/female） 8/12 8/12 9/11 n.s.
Duration of surgery（min） 91±37 92±48 96±41 n.s.
Duration of anesthesia（min） 157±45 151±42 161±40 n.s.
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line among the three groups （Fig. 1）. After induction 
of anesthesia, MAP decreased significantly compared 
with the baseline values in all groups. One minute af-
ter intubation, MAP increased significantly in the sa-
line and landiolol groups, and those were significantly 
higher than that of the remifentanil group from one to 
5 minutes after tracheal intubation. MAP in the re-
mifentanil group remained lower than the baseline val-
ing Scheffé’s test. The threshold for statistical signifi-
cance was P＜0.05.
???????
There were no significant differences in age, gender, 
body weight, height, and durations of surgery and an-
esthesia among the three groups （Table 1）.
There was no significant difference in MAP at base-
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????????　 Changes in heart rate. †P＜0.01 versus baseline. ‡P＜0.05 versus baseline. ＊P＜
0.01 versus saline. ＊＊P＜0.05 versus saline. Values are shown as mean±SD.
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????????　 Changes in mean arterial pressure. †P＜0.01 versus baseline. ‡P＜0.05 versus 
baseline. ＊P＜0.01 versus saline. ＃P＜0.01 versus landiolol. ＃＃P＜0.05 versus 
landiolol. Values are shown as mean±SD.
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groups compared with the baseline values （baseline, 
215±69 pg/mL and 222±65 pg/mL；with the peak at 
immediately after tracheal intubation, 333±151 pg/mL 
and 346±112 pg/mL；P＜0.01）. However, these of the 
remifentanil group decreased significantly compared 
with the baseline value during the study （baseline, 216
±92 pg/mL；with the peak at immediately after tra-
cheal intubation, 160±82 pg/mL；P＜0.05）, and were 
significantly lower than those of the saline and landi-
olol groups from one to 10 minutes after tracheal intu-
bation.
BIS values decreased significantly compared with 
the baseline values during the study in all groups （Fig. 
5）. These of the remifentanil group were significantly 
lower than those of the saline and landiolol groups 
from one to 10 minutes after tracheal intubation.
PETCO2 was maintained at 36 and 39 mm Hg during 
the study in three groups.
There were no severe adverse events, such as car-
diovascular event, arrhythmia, hypoxemia, respiratory 
dysfunction, delayed recovery, anaphylactic reaction 
and others in all groups.
??????????
Tracheal intubation is a noxious stimulus which in-
duces adverse hemodynamic responses. Many drugs 
have been used to attenuate adverse hemodynamic re-
ue during the study.
As shown in Fig. 2 , there was no significant differ-
ence in HR at baseline among the three groups. One 
minute after tracheal intubation, HR increased signifi-
cantly compared with the baseline value in the saline 
group, and decreased significantly in the landiolol 
group. HR in the saline group was significantly higher 
than those of the remifentanil and landiolol groups 
from one to 10 minutes after tracheal intubation. HR in 
the remifentanil and landiolol groups remained lower 
than the baseline values during the study.
No statistically significant difference was observed 
in plasma concentration of adrenaline at baseline 
among the three groups （80±31 pg/mL in the saline 
group；77±53 pg/mL in the remifentanil group；74±
41 pg/mL in the landiolol group）（Fig. 3）. Plasma con-
centration of adrenaline decreased significantly during 
the study in all groups. One minute after tracheal intu-
bation, adrenaline plasma level in the remifentanil 
group was significantly lower than those of the saline 
and landiolol groups （53±31 pg/mL in the saline 
group；29±14 pg/mL in the remifentanil group；52±
31 pg/mL in the landiolol group）.
Changes of plasma concentration of noradrenaline 
are shown in Fig. 4 . Plasma concentrations of nora-
drenaline increased significantly from one to 5 minutes 
after tracheal intubation in the saline and landiolol 
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????????　 Changes in plasma concentration of adrenaline. †P＜0.01 versus baseline. ‡P＜0.05 
versus baseline. ＊P＜0.01 versus saline. ＃P＜0.01 versus landiolol. Values are 
shown as mean±SD.
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half-life of approximately 3 . 7 hours. Therefore, re-
mifentanil is preferable to fentanyl during tracheal in-
tubation.
b-adrenoceptor antagonists, such as esmolol and la-
betalol, are also used to prevent hypertension and 
tachycardia induced by tracheal intubation because 
these agents have potent effects when activity of the 
sympathetic nervous system is increased. Landiolol, a 
newly developed ultra-short-acting b 1-adrenoceptor 
sponses to laryngoscopy and intubation, but none is 
ideal 18）. Narcotics, such as fentanyl and remifentanil, 
have been used to prevent hyperdynamic responses 
induced by laryngoscopy and tracheal intubation. Re-
mifentanil metabolized by tissue and plasma esterases 
has a more rapid onset of analgesic action than that of 
fentanyl which occurs within 1 to 1.5 minutes, and the 
elimination half-life is 8 to 20 minutes19）. Its half-life is 
significantly shorter than that of fentanyl which has a 
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????????　 Changes in plasma concentration of noradrenaline. †P＜0.01 versus baseline. ‡P＜
0.05 versus baseline. ＊P＜0.01 versus saline. ＃P＜0.01 versus landiolol. Values are 
shown as mean±SD.
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????????　 Changes in bispectral index. †P＜0.01 versus baseline. ＊P＜0.01 versus saline. ＊＊P
＜0.05 versus saline. ＃P＜0.01 versus landiolol. ＃＃P＜0.05 versus landiolol. Values 
are shown as mean±SD.
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A 1-minute loading infusion of landiolol 0.125 mg/kg 
followed by an infusion of landiolol 0 .04 mg/kg/min 
was used in this study because the dosage of landiolol 
was determined on the basis of its effectiveness in re-
ducing the hemodynamic response to tracheal intuba-
tion under sevoflurane anesthesia22,23）. The dosage of 
landiolol may affect our results. Further studies need 
to discuss about the action of landiolol to prevent car-
diovascular changes after tracheal inbtubation.
BIS monitoring can currently be considered the ac-
cepted standard on depth of anesthesia. In the present 
study, the BIS values in the three groups decreased 
significantly after induction of anesthesia and these in 
the remifentanil group were significantly lower than 
those of the landiolol and saline groups after tracheal 
intubation because the antinociceptive effect of re-
mifentanil blunted increases in BIS values after intuba-
tion9,24）. However, previous studies have also shown 
that b 1-adrenoceptor antagonists blunt hemodynamic 
response to tracheal intubation and suppress increases 
of BIS values under propofol anesthesia although the 
mechanism is not fully elucidated25,26）. The discrepancy 
between our results and the previous reports may be 
explained by the dosage of propofol and the duration 
from the induction of anesthesia to tracheal intubation. 
In the present study, anesthesia was induced with in-
travenous injection of propofol 2 mg/kg. Since propofol 
has been reported to suppress hemodynamic and plas-
ma catecholamine responses27〜29）, the agent affected 
decreases of MAP, HR and plasma adrenaline and no-
radrenaline levels after induction of anesthesia. Contin-
uous infusion of propofol was not performed after the 
bolus injection in this study, but it was performed in 
the previous studies. Therefore, the total dosage of 
propofol in this study was less than those of the previ-
ous studies. Tracheal intubation was performed 5 min-
utes after induction of anesthesia in this study, but 7 
minutes in the previous study. It is possible that con-
tinuous infusion of propofol for 7 minutes exerts an in-
fluence on hemodynamic responses during tracheal in-
tubation in the previous studies. Additional studies are 
necessary to firmly establish whether b 1-adrenoceptor 
antagonists suppress hemodynamic response without 
anesthesia.
In conclusion, a 1-minute loading infusion of remifen-
tanil 0.5 mg/kg followed by an infusion of remifentanil 
antagonist, has recently been used to avoid adverse 
hemodynamic responses caused by intubation. Landi-
olol is rapidly hydrolyzed to an inactive metabolite 
M-1 by both pseudocholinesterase in the plasma and 
carboxylesterase in the liver, and excreted in the 
urine, resulting in an elimination half-life of approxi-
mately 3.5 minutes20）. Its half-life is significantly short-
er than that of esmolol which has a half-life of 9.2 min-
utes21）.
In the present study, we compared remifentanil with 
landiolol to examine the effects of hemodynamic re-
sponses to tracheal intubation. Plasma concentration of 
adrenaline decreased significantly after induction of 
anesthesia in all groups. The plasma adrenaline levels 
in the remifentanil group were unchanged after tra-
cheal intubation, whereas that in the landiolol and sa-
line groups increased after intubation. Although the 
plasma noradrenaline level increased after tracheal in-
tubation in the landiolol and saline groups, that re-
mained low level after tracheal intubation. No statisti-
cally significant differences were observed in plasma 
adrenaline and noradrenaline levels between the landi-
olol and saline groups after tracheal intubation. These 
results suggest that remifentanil is preferable to landi-
olol to prevent systemic catecholamines releases after 
tracheal intubation.
Mean arterial pressure in all groups decreased sig-
nificantly after induction of anesthesia. However, MAP 
in the landiolol and saline groups increased significant-
ly compared with that of the remifentanil group after 
intubation, and returned to the baseline value. No sta-
tistically significant difference was observed in MAP 
between the landiolol and saline groups after intuba-
tion. Heart rate in the remifentanil and landiolol groups 
decreased steadily after intubation. From these results, 
remifentanil suppresses increases in MAP and HR af-
ter intubation, whereas landiolol suppresses an in-
crease in HR, not MAP. Increase in MAP after trache-
al intubation may contribute to systemic catecholamine 
releases in the landiolol and saline groups. On the oth-
er hand, landiolol may have an only effect to reduce 
activity of the sympathetic nervous system after sys-
temic catecholamine releases due to tracheal intuba-
tion. Our data suggested that remifentanil might be 
preferable to prevent noxious stimulus of tracheal in-
tubation.
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0.25 mg/kg/min suppresses hemodynamic and plasma 
catecholamine responses after tracheal intubation. 
However, a bolus of landiolol 0.125 mg/kg followed by 
an infusion of landiolol 0.04 mg/kg/min, which is used 
in clinical practice, may not suppress plasma cate-
cholamine response during tracheal intubation.
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